View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/SAMHSA | RIN: 0930-AA27 | Publication ID: Fall 2018 |
Title: Revising Outdated Requirements for Opioid Treatment Providers (OTPS) | |
Abstract:
This planned deregulatory action would revise 42 CFR part 8 to reduce outmoded requirements. First, SAMSHA may streamline the regulation by deleting now outdated requirements pertaining to transitional certification for opioid treatment programs (OTPs). This change will help make the regulation less confusing by removing a provision that no longer applies. Second, SAMSHA may alter requirements pertaining to interim maintenance treatment program approval. |
|
Agency: Department of Health and Human Services(HHS) | Priority: Other Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
Major: Undetermined | Unfunded Mandates: No |
EO 13771 Designation: Deregulatory | |
CFR Citation: 42 CFR 8 | |
Legal Authority: sec. 303(g) of the Controlled Substances Act (CSA) 21 U.S.C. 823(g) |
Legal Deadline:
None |
||||||
Statement of Need: SAMHSA plans to promulgate a rule to remove the transitional certification provisions that are now outdated. Additionally, updating language to permit private, for-profit entities to serve as opioid treatment programs could improve patient access to this treatment. This planned deregulatory action would revise 42 CFR Part 8 to reduce outmoded requirements. First, SAMSHA may streamline the regulation by deleting now outdated requirements pertaining to transitional certification for opioid treatment programs (OTPs). This change will help make the regulation less confusing by removing a provision that no longer applies. Second, SAMSHA may alter requirements pertaining to interim maintenance treatment program approval |
||||||
Summary of the Legal Basis: Section 303(g) of the Controlled Substances Act (CSA) (21 U.S.C. 823(g) establishes procedures for determining whether a healthcare practitioner can dispense opioid drugs for the purpose of treating opioid use disorders. HHS has adopted regulations at 42 CFR Part 8 to provide additional details. These regulations were most recently substantively revised in July 2016 (81 FR 44712). |
||||||
Alternatives: The alternatives include not making these changes or making only one of the above changes rather than both. |
||||||
Anticipated Costs and Benefits: Eliminating outmoded transition regulations will make the regulations less confusing. In addition, permitting private, for-profit entities to qualify for certification potentially will broaden access to opioid treatment programs. SAMHSA is unsure how to quantify costs and benefits for these changes. |
||||||
Risks: The transition provisions are outdated and no longer apply. SAMSHA anticipates most stakeholders will support permitting private, for-profit entities to serve as OTPs but some may be skeptical of these entities as compared to nonprofits. Rescinding the reporting requirements for providers treating up to 275 patients should hold minimal risk since these providers still are bound by other certification requirements such as recordkeeping, etc. These reporting requirements initially were added in July 2016 (81 FR 66191). |
||||||
Timetable:
|
Regulatory Flexibility Analysis Required: Undetermined | Government Levels Affected: Local, State, Tribal |
Federalism: No | |
Included in the Regulatory Plan: Yes | |
RIN Data Printed in the FR: No | |
Agency Contact: Chris Carroll Director of Health Care Financing and Systems Integration Department of Health and Human Services Substance Abuse and Mental Health Services Administration 5600 Fishers Lane, Rockville, MD 20857 Phone:240 276-1765 Email: christopher.carroll@samhsa.hhs.gov |